Thank you for the warm welcome and the information. I work for a biologic medical device company. We had our full 13485 audit last week. One of the auditors commented we really needed to reference the EU Pharmacopeia. We don't even reference the US Pharmacopeia. He couldn't really give me a reason except for "just because". I think it's silly to spend ~$1000 for something to sit on a shelf. I think as long as I can show there aren't any significant differences I'm going to push back on this.
My guess is that... You might following ISO standards/guidance for establishing various activities in your process. Look if there are any equivalent monographs in USP/BP/EP .
btw, Relevance of pharmacopoeia in your context could be even certain general monographs/chapters pertaining to "compatibility of materials" and "extractables and leachables"; Pharmacopoeia also has certain monographs on metrology (measurements, weights, calbirations, validations) etc.,
Since you say it is pertaining to expectation set by auditor, if you can indicate specific category/type of device OR context of discussion, we would try to possibly suggest few points.
But generally speaking...differences exist in most of the places relevant to dossiers; (viz., no. of batches, stability, ) and data presentation&evaluation (viz., listing of impurities) ... and special areas of TSE/BSE certifications, etc.,and to the extent of emphasis on review comments,.
In the meanwhile, try to look into following references...
Pharmacopoeial Standards for Medicines in the Australia New Zealand Therapeutic Products Agency
http://www.anztpa.org/consult/pharmacopoeia.pdf
Pharmacopoeial Reference Standards
http://www.ipapharma.org/events/IPA%20-%20EDQM%20pdf/Antony%20Gomes%20-%20reference%20standards.pdf
Hope that it helps.